Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 619

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Integrated PET/CT: Current Applications and Future Directions

von Schulthess, Gustav K., Steinert, Hans C., Hany, Thomas F. · 2006 · Radiology

Abstract

For the past 5 years, combined positron emission tomography (PET) and computed tomography (CT), or PET/CT, has grown because the PET portion provides information that is very different from that obtainable with other imaging modalities. However, the paucity of anatomic landmarks on PET images makes a consistent "hardware fusion" to anatomic cross-sectional data extremely useful. Clinical experience indicates a single direction: Addition of CT to PET improves specificity foremost, but also sensitivity, and the addition of PET to CT adds sensitivity and specificity in tumor imaging. Thus, PET/CT is a more accurate test than either of its individual components and is probably also better than side-by-side viewing of images from both modalities. The synergistic advantage of adding CT is that the attenuation correction needed for PET can also be derived from the CT data, an advantage not obtainable by integrating PET and magnetic resonance imaging. This makes PET/CT 25%-30% faster than PET alone with standard attenuation-correction methods, leading to higher patient throughput and a more comfortable examination, which typically last 30 minutes or less. Fluorodeoxyglucose (FDG) PET/CT appears to provide relevant information in the staging and therapy monitoring of many tumors, including lung carcinoma, mesothelioma, colorectal cancer, lymphoma, melanoma, and many others, with the notable exception of prostatic cancer. For prostatic cancer, choline derivatives may become useful radiopharmaceuticals. The published literature on the applications of FDG PET/CT in oncology is still limited, but several well-designed studies have demonstrated the benefits of PET/CT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1148/radiol.2382041977

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 25

  1. Nehmeh SA, Erdi YE, Kalaigian H, et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT.J Nucl Med2003;44:1940–1944.
  2. 10.1007/s00259-002-1055-3 · doi:10.1007/s00259-002-1055-3
  3. 10.1007/s00261-003-0163-2 · doi:10.1007/s00261-003-0163-2
  4. 10.1016/S0003-4975(00)01817-8 · doi:10.1016/s0003-4975(00)01817-8
  5. 10.1067/msy.2001.116919 · doi:10.1067/msy.2001.116919
  6. 10.1148/radiol.2323031065 · doi:10.1148/radiol.2323031065
  7. 10.1007/s00259-004-1633-7 · doi:10.1007/s00259-004-1633-7
  8. 10.1093/annonc/mdf664 · doi:10.1093/annonc/mdf664
  9. 10.3816/CLM.2002.n.012 · doi:10.3816/clm.2002.n.012
  10. 10.2214/ajr.182.6.1821579 · doi:10.2214/ajr.182.6.1821579
  11. Kitagawa Y, Nishizawa S, Sano K, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.J Nucl Med2003;44:198–206.
  12. 10.1148/radiol.2311030271 · doi:10.1148/radiol.2311030271
  13. Rogers JW, Greven KM, McGuirt WF, et al.Can post-RT neck dissection be omitted for patients with head-and-neck cancer who have a negative PET scan after definitive radiation therapy? Int J Radiat Oncol Biol Phys2004;58:694–697. · doi:10.1016/s0360-3016(03)01625-0
  14. 10.1148/radiol.2332031800 · doi:10.1148/radiol.2332031800
  15. Picchio M, Sironi S, Messa C, et al. Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.Q J Nucl Med2003;47:77–84.
  16. 10.1002/1097-0142(19920601)69:11<2796::AID-CNCR2820691127>3.0.CO;2-O · doi:10.1002/1097-0142(19920601)69:11<2796::aid-cncr2820691127>3.0.co;2-o
  17. 10.1016/j.ygyno.2004.05.053 · doi:10.1016/j.ygyno.2004.05.053
  18. 10.1007/s00259-004-1536-7 · DOI
  19. Dizendorf E, Baumert B, von Schulthess GK, Luetolf UM, Steinert HC. The impact of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) on planning of radiotherapy [in Russian].Ter Arkh2001;73:11–14.
  20. 10.1046/j.1464-410X.2003.04297.x · doi:10.1046/j.1464-410x.2003.04297.x
  21. 10.1111/j.1464-410X.2003.04692.x · doi:10.1111/j.1464-410x.2003.04692.x
  22. 10.1148/radiol.2352040494 · doi:10.1148/radiol.2352040494
  23. 10.1016/S0969-8051(03)00097-0 · doi:10.1016/s0969-8051(03)00097-0
  24. de Winter F, van de Wiele C, Vogelaers D, de Smet K, Verdonk R, Dierckx RA. Fluorine-18 fluorodeoxyglucose-position emission tomography: a highly accurate imaging modality for the diagnosis of chronic musculoskeletal infections.J Bone Joint Surg Am2001; 83-A:651–660. · doi:10.2106/00004623-200105000-00002
  25. 10.1148/radiol.2312021596 · doi:10.1148/radiol.2312021596

Cited by

See all 619

Metadata

Authors
von Schulthess, G. K., Steinert, H. C., & Hany, T. F.
Venue
Radiology
Published
2006-02
Volume
238
Issue
2
Pages
405-422
ISSN
  • 0033-8419 (ISSN-L)
  • 1527-1315
OpenAlex
W2020657588
Cited by
619
References
54
FWCI
48.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.